European journal of gynaecological oncology 2013-01-01

A rare case of lymphangiomyomatosis treated with leuprolide acetate: five-years follow-up.

E Bastu, S E Akhan, B Karamustafaoglu, F Gungor-Ugurlucan, H Sozen, A C Iyibozkurt

Index: Eur. J. Gynaecol. Oncol. 34(3) , 278-9, (2013)

Full Text: HTML

Abstract

Lymphangiomyomatosis (LAM) is a rare and systemic disease that is characterized by the abnormal proliferation of smooth muscle-like cells in the lungs and along the axial lymphatic system. The authors herein present a rare case of LAM that was treated with long-term use of leuprolide acetate, a gonadotropin-releasing hormone analogue (GnRHa).

Related Compounds

Structure Name/CAS No. Articles
Leuprolide TFA Structure Leuprolide TFA
CAS:53714-56-0